ChemPartner Opens South San Francisco, California, Research Facility
A service division of the ShangPharma group, ChemPartner, is a leading research organization providing high-quality and cost-effective services for the pharmaceutical and biotechnology industry. ChemPartner's new research facility will be staffed by experienced drug research scientists from leading biotechnology companies who will collaborate closely with ChemPartner's scientists based in China.
"We are very excited to announce the opening of ChemPartner's new state-of-the-art research facility in South San Francisco, one of the global centers of innovation in life science," said ChemPartner Founder/CEO Michael Hui.
"In drug discovery, scientific excellence is the key to success," Hui continued. "By taking the CRO service business to the next level, this new facility will help enable our customers, partners, and business collaborators to interrogate the most complex of drug discovery projects."
The Company noted that the new facility is the first step in a planned build-out of ChemPartner's research presence in major innovation hubs around the world. "In addition to proximity to the top industry talent, the new facility brings ChemPartner services closer to the biopharmaceutical communities in the United States, and will enable us to develop more innovative ways to bring value to our partners," company officials said.
Vigilent Labs Plans $104.6 Million Headquarters & Operations Campus in North Charleston, South Carolina
Glock Manufacturer GS Performance Relocates Headquarters & Operations to Nashville, Tennessee
The New Normal in the Automotive Supply Chain
2020 Auto/Aero Site Guide
Why are Foreign Trade Zones Making a Comeback?
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Infrastructure Investment as an Economic Stimulus Tool
The Next Recovery: Regional Leaders & Laggards